CYP2D6变异与表达特征参与精神分裂症风险
该研究整合1497例RNA-seq数据与基因型数据,通过eGene和eJunction分析联合SMR与精细定位,识别出171个基因和4个基因内的8个剪接连接点可能贡献精神分裂症易感性。CYP2D6在eGene和eJunction层面均与精神分裂症GWAS显著关联,rs16947与外显子3跳跃连接点丰度升高强相关,且CYP2D6显著参与可待因、他莫昔芬和西酞普兰的药物代谢。
要点
- CYP2D6的eGene和eJunction信号与精神分裂症GWAS显著共定位。
- rs16947与CYP2D6外显子3跳跃连接点丰度升高强相关。
- CYP2D6显著参与可待因、他莫昔芬和西酞普兰的代谢。
核心结论
- CYP2D6的变异与表达特征可能通过影响剪接和药物代谢参与精神分裂症易感性。
研究设计与样本
- 分析1497例RNA-seq数据及其基因型数据,识别eGene和eJunction。
- 用SMR和精细定位将eGene与eJunction与精神分裂症GWAS共定位。
- 利用脑组织ChIP-seq和DNA甲基化数据识别因果变异。
- 采用无假设富集分析确定相关通路。
主要发现
- 识别出171个基因和4个基因(SNX19、ARL6IP4、APOPT1、CYP2D6)内的8个剪接连接点可能贡献精神分裂症易感性。
- CYP2D6在eGene和eJunction层面均与精神分裂症SNP显著关联。
- rs16947与CYP2D6外显子3跳跃连接点丰度升高强相关。
- rs133377等与rs16947高度连锁不平衡(r2=0.9539)的功能性SNP位于活跃转录起始位点。
- CYP2D6显著参与可待因、他莫昔芬和西酞普兰的药物代谢。
关键数值与推荐
- rs16947与rs133377等SNP的连锁不平衡r2=0.9539。
- 共定位分析识别171个基因和8个剪接连接点。
临床怎么用
- 提示CYP2D6剪接调控和药物代谢通路可能是精神分裂症潜在药物靶点。
- 临床关注CYP2D6相关药物代谢可能为精神分裂症个体化治疗提供参考。
局限性
- 研究基于RNA-seq和遗传数据整合分析,未报告独立样本验证或功能实验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Genome-wide association studies (GWAS) have successfully identified 145 loci implicated in schizophrenia (SCZ). However, the underlying mechanisms remain largely unknown. Here, we analyze 1497 RNA-seq data in combination with their genotype data and identify SNPs that are associated with expression throughout the genome by dissecting expression features to genes (eGene) and exon-exon junctions (eJunction). Then, we colocalize eGene and eJunction with SCZ GWAS using SMR and fine mapping. Multiple ChIP-seq data and DNA methylation data generated from brain were used for identifying the causal variants. Finally, we used a hypothesis-free (no SCZ risk loci considered) enrichment analysis to determine implicated pathways. We identified 171 genes and eight splicing junctions located within four genes (SNX19, ARL6IP4, APOPT1, and CYP2D6) that potentially contribute to SCZ susceptibility. Among the genes, CYP2D6 is significantly associated with SCZ SNPs in eGene and eJunction. In-depth examination of the CYP2D6 region revealed that a nonsynonymous single nucleotide variant rs16947 is strongly associated with a higher abundance of CYP2D6 exon 3 skipping junctions. While we found rs133377 and other functional SNPs in high linkage disequilibrium with rs16947 (r2 = 0.9539), histone acetylation analysis showed they are located within active transcription start sites. Furthermore, our data-driven enrichment analysis showed that CYP2D6 is significantly involved in drug metabolism of codeine, tamoxifen, and citalopram. Our study facilitates an understanding of the genetic architecture of SCZ and provides new drug targets.
引用
- Ma L, Shcherbina A, Chetty S, et al. Variations and expression features of CYP2D6 contribute to schizophrenia risk. Mol Psychiatry. 2020. PMID: 32047265. doi:10.1038/s41380-020-0675-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。